chr19-3770967-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001319074.4(RAX2):​c.217-8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.17 in 1,550,918 control chromosomes in the GnomAD database, including 23,436 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 1885 hom., cov: 33)
Exomes 𝑓: 0.17 ( 21551 hom. )

Consequence

RAX2
NM_001319074.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00005479
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 2.18

Publications

7 publications found
Variant links:
Genes affected
RAX2 (HGNC:18286): (retina and anterior neural fold homeobox 2) This gene encodes a homeodomain-containing protein that plays a role in eye development. Mutation of this gene causes age-related macular degeneration type 6, an eye disorder resulting in accumulations of protein and lipid beneath the retinal pigment epithelium and within the Bruch's membrane. Defects in this gene can also cause cone-rod dystrophy type 11, a disease characterized by the initial degeneration of cone photoreceptor cells and resulting in loss of color vision and visual acuity, followed by the degeneration of rod photoreceptor cells, which progresses to night blindness and the loss of peripheral vision. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
RAX2 Gene-Disease associations (from GenCC):
  • retinitis pigmentosa
    Inheritance: AR Classification: DEFINITIVE, MODERATE Submitted by: G2P, Franklin by Genoox
  • cone-rod dystrophy 11
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa 95
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 19-3770967-G-A is Benign according to our data. Variant chr19-3770967-G-A is described in ClinVar as Benign. ClinVar VariationId is 96230.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.177 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAX2NM_001319074.4 linkc.217-8C>T splice_region_variant, intron_variant Intron 2 of 2 ENST00000555633.3 NP_001306003.2 Q96IS3
RAX2NM_032753.4 linkc.217-8C>T splice_region_variant, intron_variant Intron 2 of 2 NP_116142.1 Q96IS3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAX2ENST00000555633.3 linkc.217-8C>T splice_region_variant, intron_variant Intron 2 of 2 1 NM_001319074.4 ENSP00000450456.3 Q96IS3
RAX2ENST00000555978.5 linkc.217-8C>T splice_region_variant, intron_variant Intron 2 of 2 1 ENSP00000450687.2 Q96IS3

Frequencies

GnomAD3 genomes
AF:
0.151
AC:
23000
AN:
152068
Hom.:
1884
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.120
Gnomad AMI
AF:
0.199
Gnomad AMR
AF:
0.138
Gnomad ASJ
AF:
0.161
Gnomad EAS
AF:
0.0251
Gnomad SAS
AF:
0.156
Gnomad FIN
AF:
0.156
Gnomad MID
AF:
0.177
Gnomad NFE
AF:
0.180
Gnomad OTH
AF:
0.165
GnomAD2 exomes
AF:
0.158
AC:
24393
AN:
154002
AF XY:
0.163
show subpopulations
Gnomad AFR exome
AF:
0.129
Gnomad AMR exome
AF:
0.130
Gnomad ASJ exome
AF:
0.161
Gnomad EAS exome
AF:
0.0206
Gnomad FIN exome
AF:
0.173
Gnomad NFE exome
AF:
0.198
Gnomad OTH exome
AF:
0.182
GnomAD4 exome
AF:
0.172
AC:
240457
AN:
1398732
Hom.:
21551
Cov.:
30
AF XY:
0.172
AC XY:
118949
AN XY:
692290
show subpopulations
African (AFR)
AF:
0.123
AC:
4009
AN:
32564
American (AMR)
AF:
0.130
AC:
4885
AN:
37680
Ashkenazi Jewish (ASJ)
AF:
0.157
AC:
3986
AN:
25318
East Asian (EAS)
AF:
0.0281
AC:
1060
AN:
37698
South Asian (SAS)
AF:
0.159
AC:
12920
AN:
81208
European-Finnish (FIN)
AF:
0.161
AC:
5548
AN:
34456
Middle Eastern (MID)
AF:
0.214
AC:
1175
AN:
5500
European-Non Finnish (NFE)
AF:
0.182
AC:
197225
AN:
1085808
Other (OTH)
AF:
0.165
AC:
9649
AN:
58500
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
11214
22428
33641
44855
56069
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6846
13692
20538
27384
34230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.151
AC:
23018
AN:
152186
Hom.:
1885
Cov.:
33
AF XY:
0.150
AC XY:
11186
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.121
AC:
5007
AN:
41522
American (AMR)
AF:
0.138
AC:
2108
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.161
AC:
559
AN:
3470
East Asian (EAS)
AF:
0.0251
AC:
130
AN:
5170
South Asian (SAS)
AF:
0.155
AC:
751
AN:
4830
European-Finnish (FIN)
AF:
0.156
AC:
1655
AN:
10618
Middle Eastern (MID)
AF:
0.180
AC:
53
AN:
294
European-Non Finnish (NFE)
AF:
0.180
AC:
12229
AN:
67968
Other (OTH)
AF:
0.163
AC:
345
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1029
2059
3088
4118
5147
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
270
540
810
1080
1350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.169
Hom.:
411
Bravo
AF:
0.150
Asia WGS
AF:
0.0940
AC:
328
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Apr 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 29, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cone-rod dystrophy 11 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Age related macular degeneration 6 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
6.0
DANN
Benign
0.92
PhyloP100
2.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000055
dbscSNV1_RF
Benign
0.0060
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79588413; hg19: chr19-3770965; API